Family impact of Rotavirus Gastroenteritis in Taiwan and Vietnam: an Ethnographic Study

BMC Infectious Diseases

Núria Lara⁷  Montse Pedros³  Phuc Le Hoang²  Chieh-Chung Lin⁴  Lung-Huang Lin⁶  Hung-Chang Lee⁵  Sònia Rojas-Farreras³  Megan A. O’Brien¹ 

[1]Merck & Co., Inc., Whitehouse Station, NJ, USA

[2]Children’s Hospital # 1, Ho Chi Minh City, Vietnam

[3]IMS Health, Barcelona, Spain

[4]Department of Pediatrics, Taichung Veterans General Hospital, Taichung, Taiwan

[5]Department of Pediatrics, MacKay Memorial Hospital, Hsinchu, Taiwan

[6]Department of Pediatrics, Cathay General Hospital, Taipei, Taiwan & School of Medicine, Fu-Jen Catholic University, New Taipei City, Taiwan

[7]IMS Health, Doctor Ferran 25-27 2°, Barcelona, 08034, Spain

关键词: Emotional impact;    Economic impact;    Focus groups;    Ethnographic study;    Family impact;    Vietnam;    Taiwan;    Asia;    Rotavirus infection;   

Others  :  1230337
DOI  :  10.1186/s12879-015-0968-y

 received in 2014-05-15, accepted in 2015-05-29,  发布年份 2015

【 摘 要 】

Background

Prior to the introduction of rotavirus vaccines, rotavirus was the leading cause of severe gastroenteritis in infants and young children, and it continues to be the leading cause in countries without vaccination programs. Rotavirus gastroenteritis results in substantial economic burden and has a pronounced effect on the family of those who are ill. Both in Taiwan and in Vietnam, rotavirus illness is viewed as a priority disease. This study assessed, in Taiwan and Vietnam, the impact of rotavirus gastroenteritis on the family among a group of parents whose children had recently been hospitalized for this illness.

Methods

In the first half of 2013, parents of children who had been hospitalized due to rotavirus infection were recruited from hospitals in Taiwan (n = 12) and Vietnam (n = 22), and participated in focus group sessions or in-depth ethnographic interviews.

Results

In both countries, the results point to a substantial burden on the parents concerning emotions and logistics of daily tasks, and to considerable disruptions of the family routine. Taiwanese parents reported satisfaction with the health care system, a great deal of effort to suppress emotions, a fair amount of knowledge about rotavirus, and little extra costs related to the illness. On the other hand, parents in Vietnam expressed concern about the emotional well-being of and the health care treatments for their children, were less knowledgeable regarding rotavirus infection, and experienced a substantial financial burden due to indirect costs that were related to accessing treatment.

Conclusions

Families in Taiwan and Vietnam suffer from a considerable economic and emotional burden related to rotavirus gastroenteritis. One way to substantially reduce this burden is to provide universal and affordable rotavirus vaccination to susceptible children, especially since cost-effectiveness studies have demonstrated that universal vaccination would be safe and efficacious against severe rotavirus gastroenteritis in these countries.

【 授权许可】

   
2015 O'Brien et al.

【 参考文献 】

• [1]Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis. 2012; 12:136-41.
• [2]Glass RI, Parashar UD, Bresee JS, Turcios R, Fischer TK, Widdowson MA, Jiang B, Gentsch JR. Rotavirus vaccines: current prospects and future challenges. Lancet. 2006; 368:323-32.
• [3]Dennehy PH. Rotavirus infection: an update on management and prevention. Adv Pediatr. 2012; 59:47-74.
• [4]Parashar UD, Burton A, Lanata C, Boschi-Pinto C, Shibuya K, Steele D, Birmingham M, Glass RI. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis. 2009; 200 Suppl 1:S9-15.
• [5]Kawai K, O’Brien MA, Goveia MG, Mast TC, El Khoury AC. Burden of rotavirus gastroenteritis and distribution of rotavirus strains in Asia: a systematic review. Vaccine. 2012; 30:1244-54.
• [6]Luan le T, Trang NV, Phuong NM, Nguyen HT, Ngo HT, Nguyen HT, Tran HB, Dang HN, Dang AD, Gentsch JR et al.. Development and characterization of candidate rotavirus vaccine strains derived from children with diarrhoea in Vietnam. Vaccine. 2009; 27 Suppl 5:130-8.
• [7]Chen KT, Chen PY, Tang RB, Huang YF, Lee PI, Yang JY, Chen HY, Bresee J, Hummelman E, Glass R. Sentinel hospital surveillance for rotavirus diarrhea in Taiwan, 2001-2003. J Infect Dis. 2005; 192 Suppl 1:S44-8.
• [8]Chang CW, Chen PY, Huang FL. Epidemiology of diarrhea among young children: a questionnaire-based study in Taiwan. J Microbiol Immunol Infect. 2009; 42:265-70.
• [9]Yang SY, Hwang KP, Wu FT, Wu HS, Hsiung CA, Chang WC, Lin JS, Yang SC, Huang SL, Huang YC. Epidemiology and clinical peculiarities of norovirus and rotavirus infection in hospitalized young children with acute diarrhea in Taiwan, 2009. J Microbiol Immunol Infect. 2010; 43:506-14.
• [10]Mast TC, Chen PY, Lu KC, Hsu CM, Lin HC, Liao WC, Lin DP, Chen HC, Lac C. Epidemiology and economic burden of rotavirus gastroenteritis in hospitals and paediatric clinics in Taiwan, 2005-2006. Vaccine. 2010; 28:3008-13.
• [11]Nguyen TA, Yagyu F, Okame M, Phan TG, Trinh QD, Yan H, Hoang KT, Cao AT, Le Hoang P, Okitsu S et al.. Diversity of viruses associated with acute gastroenteritis in children hospitalized with diarrhea in Ho Chi Minh City, Vietnam. J Med Virol. 2007; 79:582-90.
• [12]Lu CY, Lauderdale TL, Fang YH, Wang CY, Ho YH, Hung CL, Chang LY, Lee CY, Huang LM. Disease burden and related medical costs of rotavirus infections in Taiwan. BMC Infect Dis. 2006; 6:176. BioMed Central Full Text
• [13]Van Man N, Luan le T, Trach DD, Thanh NT, Van Tu P, Long NT, Anh DD, Fischer TK, Ivanoff B, Gentsch JR et al.. Epidemiological profile and burden of rotavirus diarrhea in Vietnam: 5 years of sentinel hospital surveillance, 1998-2003. J Infect Dis. 2005; 192 Suppl 1:S127-32.
• [14]Anh DD, Thiem VD, Fischer TK, Canh DG, Minh TT, Tho le H, Van Man N, Luan le T, Kilgore P, von Seidlein L et al.. The burden of rotavirus diarrhea in Khanh Hoa Province, Vietnam: baseline assessment for a rotavirus vaccine trial. Pediatr Infect Dis J. 2006; 25:37-40.
• [15]Mast TC, DeMuro-Mercon C, Kelly CM, Floyd LE, Walter EB. The impact of rotavirus gastroenteritis on the family. BMC Pediatr. 2009; 9:11. BioMed Central Full Text
• [16]Vesikari T, Giaquinto C, Huppertz HI. Clinical trials of rotavirus vaccines in Europe. Pediatr Infect Dis J. 2006; 25:S42-7.
• [17]Lewis K. Vesikari Clinical Severity Scoring System Manual. www.path.org/publications/files/VAD_vesikari_scoring_manual.pdf. 2011.
• [18]Johnston BC, Donen R, Pooni A, Pond J, Xie F, Giglia L, Kam A, Bhamber A, Bami K, Patel Y et al.. Conceptual framework for health-related quality of life assessment in acute gastroenteritis. J Pediatr Gastroenterol Nutr. 2013; 56:280-9.
• [19]McCormick JB, Hammer RR, Farrell RM, Geller G, James KM, Loftus EV, Mercer MB, Tilburt JC, Sharp RR. Experiences of patients with chronic gastrointestinal conditions: in their own words. Health Qual Life Outcomes. 2012; 10:25. BioMed Central Full Text
• [20]Welfare MR, Colligan J, Molyneux S, Pearson P, Barton JR. The identification of topics for research that are important to people with ulcerative colitis. Eur J Gastroenterol Hepatol. 2006; 18:939-44.
• [21]Diez DJ, Patrzalek M, Cantarutti L, Arnould B, Meunier J, Soriano-Gabarro M, Meyer N, Pircon JY, Holl K. The impact of childhood acute rotavirus gastroenteritis on the parents’ quality of life: prospective observational study in European primary care medical practices. BMC Pediatr. 2012; 12:58. BioMed Central Full Text
• [22]Chan WSH. Taiwan’s healthcare report 2010. EPMA J. 2010; 1:563-85.
• [23]Ekman B, Liem NT, Duc HA, Axelson H. Health insurance reform in Vietnam: a review of recent developments and future challenges. Health Policy Plan. 2008; 23:252-63.
• [24]Lieu TA, Thompson KM, Prosser LA, O’Brien MA, Yusuf HR, Shefer AM, Weinstein MC, Rickert DL. Emerging issues in vaccine economics: perspectives from the USA. Expert Rev Vaccines. 2002; 1:433-42.
• [25]Jin H, Wang B, Fang Z, Duan Z, Gao Q, Liu N, Zhang L, Qian Y, Gong S, Zhu Q. Hospital-based study of the economic burden associated with rotavirus diarrhea in eastern China. Vaccine. 2011; 29:7801-6.
• [26]Itzler RF, Chen PY, Lac C, El Khoury AC, Cook JR. Cost-effectiveness of a pentavalent human-bovine reassortant rotavirus vaccine for children
• [27]Anh DD, Carlos CC, Thiem DV, Hutagalung Y, Gatchalian S, Bock HL, Smolenov I, Suryakiran PV, Han HH. Immunogenicity, reactogenicity and safety of the human rotavirus vaccine RIX4414 (Rotarix) oral suspension (liquid formulation) when co-administered with expanded program on immunization (EPI) vaccines in Vietnam and the Philippines in 2006–2007. Vaccine. 2011; 29:2029-36.
• [28]Zaman K, Dang DA, Victor JC, Shin S, Yunus M, Dallas MJ, Podder G, Vu DT, Le TP, Luby SP et al.. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet. 2010; 376:615-23.
• [29]Fischer TK, Anh DD, Antil L, Cat ND, Kilgore PE, Thiem VD, Rheingans R, Tho le H, Glass RI, Bresee JS. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam. J Infect Dis. 2005; 192:1720-6.
• [30]Kim SY, Goldie SJ, Salomon JA. Cost-effectiveness of Rotavirus vaccination in Vietnam. BMC Public Health. 2009; 9:29. BioMed Central Full Text
• [31]Tu HA, Rozenbaum MH, Coyte PC, Li SC, Woerdenbag HJ, Postma MJ. Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries. Vaccine. 2012; 30:1521-8.